Coronary atherosclerosis with vulnerable plaque and complicated lesions in transplant recipients: New insight into cardiac allograft vasculopathy by optical coherence tomography

European Heart Journal

Volumn 34, Issue 33, 2013, Pages 2610-2617

  Cassar, Andrew ^a   Matsuo, Yoshiki ^a   Herrmann, Joerg ^a   Li, Jing ^a   Lennon, Ryan J ^a   Gulati, Rajiv ^a   Lerman, Lilach O ^a   Kushwaha, Sudhir S ^a   Lerman, Amir ^a  

^a Mayo Clinic College of Medicine   (United States)

Author keywords

Atherosclerosis; Cardiac allograft vasculopathy; Optical coherence tomography; Thrombus; Transplant; Vulnerable plaque

Indexed keywords

CONTRAST MEDIUM;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIAC ALLOGRAFT VASCULOPATHY; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HEART TRANSPLANTATION; HUMAN; INTRAVASCULAR ULTRASOUND; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY DEVICE; PREVALENCE; PRIORITY JOURNAL; ULTRASOUND SCANNER;

ATHEROSCLEROSIS; CARDIAC ALLOGRAFT VASCULOPATHY; OPTICAL COHERENCE TOMOGRAPHY; THROMBUS; TRANSPLANT; VULNERABLE PLAQUE;

ALLOGRAFTS; CORONARY ARTERY DISEASE; FEMALE; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; ULTRASONOGRAPHY, INTERVENTIONAL; VASCULAR CALCIFICATION;

EID: 84883750350     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/eht236     Document Type: Article

References (32)

1. Rahmani M, Cruz RP, Granville DJ, McManus BM. Allograft vasculopathy versus atherosclerosis. Circ Res 2006;99:801-815. (Pubitemid 44556379)
2. Schmauss D,Weis M. Cardiac allograft vasculopathy: recent developments. Circulation 2008;117:2131-2141. (Pubitemid 351596195)
3. Stehlik J, Edwards LB, Kucheryavaya AY, Benden C, Christie JD, Dipchand AI, Dobbels F, Kirk R, Rahmel AO, Hertz MI. The registry of the international society for heart and lung transplantation: 29th official adult heart transplant report-2012. J Heart Lung Transplant 2012;31:1052-1064.
4. Mehra MR, Crespo-Leiro MG, Dipchand A, Ensminger SM, Hiemann NE, Kobashigawa JA, Madsen J, Parameshwar J, Starling RC, Uber PA. International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010. J Heart Lung Transplant 2010;29:717-727.
5. Torres HJ, Merello L, Ramos SA, Aninat MA, Becerra LE, Mora AD, Valenzuela PT, GodoyMJ, Prieto AA. Prevalence of cardiac allograft vasculopathyassessed with coronary angiography versus coronary vascular ultrasound and virtual histology. Transpl Proc 2011;43:2318-2321.
6. Yabushita H, Bouma BE, Houser SL, AretzHT, Jang IK, Schlendorf KH, Kauffman CR, Shishkov M, Kang DH, Halpern EF, Tearney GJ. Characterization of human atherosclerosis by optical coherence tomography. Circulation 2002;106:1640-1645.
7. Prati F, Regar E, Mintz GS, Arbustini E, Di Mario C, Jang IK, Akasaka T, Costa M, Guagliumi G, Grube E, Ozaki Y, Pinto F, Serruys PW. Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis. Eur Heart J 2010;31: 401-415.
8. Tearney GJ, Regar E, Akasaka T, Adriaenssens T, Barlis P, Bezerra HG, Bouma B, Bruining N, Cho JM, Chowdhary S, Costa MA, de Silva R, Dijkstra J, Di Mario C, Dudeck D, Falk E, Feldman MD, Fitzgerald P, Garcia H, Gonzalo N, Granada JF, Guagliumi G, Holm NR, Honda Y, Ikeno F, Kawasaki M, Kochman J, Koltowski L, Kubo T, Kume T, Kyono H, Lam CC, Lamouche G, Lee DP, Leon MB, Maehara A, Manfrini O, Mintz GS, Mizuno K, Morel MA, Nadkarni S, Okura H, Otake H, Pietrasik A, Prati F, Raber L, Radu MD, Rieber J, Riga M, Rollins A, Rosenberg M, Sirbu V, Serruys PW, Shimada K, Shinke T, Shite J, Siegel E, Sonada S, Suter M, Takarada S, Tanaka A, Terashima M, Troels T, Uemura S, Ughi GJ, van Beusekom HM, van der Steen AF, van Es GA, van Soest G, Virmani R, Waxman S, Weissman NJ, Weisz G. Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the InternationalWorking Group for Intravascular Optical Coherence Tomography Standardization and Validation. J Am Coll Cardiol 2012;59:1058-1072.
9. Garrido IP, Garcia-Lara J, Pinar E, Pastor-Perez F, Sanchez-Mas J, Valdes-Chavarri M, Pascual-Figal DA. Optical coherence tomography and highly sensitivity troponin T for evaluating cardiac allograft vasculopathy. Am J Cardiol 2012;110:655-661.
10. Hou J, Lv H, Jia H, Zhang S, Xing L, Liu H, Kong J, Yu B, Jang IK. OCT assessment of allograft vasculopathy in heart transplant recipients. JACC Cardiovasc Imaging 2012;5: 662-663.
11. Raichlin E, Bae JH, Kushwaha SS, Lennon RJ, Prasad A, Rihal CS, Lerman A. Inflammatory burden of cardiac allograft coronary atherosclerotic plaque is associated with early recurrent cellular rejection and predicts a higher risk of vasculopathy progression. J Am Coll Cardiol 2009;53:1279-1286.
12. Wykrzykowska JJ, Mintz GS, Garcia-Garcia HM, Maehara A, Fahy M, Xu K, Inguez A, Fajadet J, Lansky A, Templin B, Zhang Z, de Bruyne B, Weisz G, Serruys PW, Stone GW. Longitudinal distribution of plaque burden and necrotic core-rich plaques in nonculprit lesions of patients presenting with acute coronary syndromes. JACC Cardiovasc Imaging 2012;5:S10-S18.
13. Raichlin E, Bae JH, Khalpey Z, Edwards BS, Kremers WK, Clavell AL, Rodeheffer RJ, Frantz RP, Rihal C, Lerman A, Kushwaha SS. Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation. Circulation 2007;116:2726-2733. (Pubitemid 350291245)
14. Topilsky Y, Hasin T, Raichlin E, Boilson BA, Schirger JA, Pereira NL, Edwards BS, Clavell AL, Rodeheffer RJ, Frantz RP, Maltais S, Park SJ, Daly RC, Lerman A, Kushwaha SS. Sirolimus as primary immunosuppression attenuates allograft vasculopathy with improved late survival and decreased cardiac events after cardiac transplantation. Circulation 2012;125:708-720.
15. Tuzcu EM, Kapadia SR, Tutar E, Ziada KM, Hobbs RE, McCarthy PM, Young JB, Nissen SE. High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound. Circulation 2001;103: 2705-2710. (Pubitemid 32538786)
16. Velican D, Velican C. Comparative study on age-related changes and atherosclerotic involvement of the coronary arteries of male and female subjects up to 40 years of age. Atherosclerosis 1981;38:39-50. (Pubitemid 11138605)
17. Stone GW, Maehara A, Lansky AJ, de Bruyne B, Cristea E, Mintz GS, Mehran R, McPherson J, Farhat N, Marso SP, Parise H, Templin B, White R, Zhang Z, Serruys PW. A prospective natural-history study of coronary atherosclerosis. N Engl J Med 2011;364:226-235.
18. Uemura S, Ishigami K, Soeda T, Okayama S, Sung JH, Nakagawa H, Somekawa S, Takeda Y, Kawata H, Horii M, Saito Y. Thin-cap fibroatheroma and microchannel findings in optical coherence tomography correlate with subsequent progression of coronary atheromatous plaques. Eur Heart J 2012;33:78-85.
19. Kume T, Akasaka T, Kawamoto T,Watanabe N, Toyota E, Neishi Y, Sukmawan R, Sadahira Y, Yoshida K. Assessment of coronary intima-media thickness by optical coherence tomography: comparison with intravascular ultrasound. Circ J 2005;69: 903-907. (Pubitemid 41124256)
20. MacNeill BD, Jang IK, Bouma BE, Iftimia N, Takano M, Yabushita H, Shishkov M, Kauffman CR, Houser SL, Aretz HT, DeJoseph D, Halpern EF, Tearney GJ. Focal and multi-focal plaque macrophage distributions in patients with acute and stable presentations of coronary artery disease. J Am Coll Cardiol 2004;44:972-979. (Pubitemid 39165129)
21. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, Fayad Z, Stone PH, Waxman S, Raggi P, Madjid M, Zarrabi A, Burke A, Yuan C, Fitzgerald PJ, Siscovick DS, de Korte CL, Aikawa M, Juhani Airaksinen KE, Assmann G, Becker CR, Chesebro JH, Farb A, Galis ZS, Jackson C, Jang IK, Koenig W, Lodder RA, March K, Demirovic J, Navab M, Priori SG, Rekhter MD, Bahr R, Grundy SM, Mehran R, Colombo A, Boerwinkle E, Ballantyne C, Insull W Jr, Schwartz RS, Vogel R, Serruys PW, Hansson GK, Faxon DP, Kaul S, Drexler H, Greenland P, Muller JE, Virmani R, Ridker PM, Zipes DP, Shah PK, Willerson JT. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 2003;108:1664-1672. (Pubitemid 37243650)
22. Kitabata H, Tanaka A, Kubo T, Takarada S, Kashiwagi M, Tsujioka H, Ikejima H, Kuroi A, Kataiwa H, Ishibashi K, Komukai K, Tanimoto T, Ino Y, Hirata K, Nakamura N, Mizukoshi M, Imanishi T, Akasaka T. Relation of microchannel structure identified by optical coherence tomography to plaque vulnerability in patients with coronary artery disease. Am J Cardiol 2010;105:1673-1678.
23. Kubo T, Imanishi T, Takarada S, Kuroi A, Ueno S, Yamano T, Tanimoto T, Matsuo Y, Masho T, Kitabata H, Tsuda K, TomobuchiY, Akasaka T. Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. J Am Coll Cardiol 2007;50:933-939. (Pubitemid 47313602)
24. Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the vulnerable plaque. J Am Coll Cardiol 2006;47:C13-C18.
25. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000;20:1262-1275. (Pubitemid 30262927)
26. BurkeAP, Kolodgie FD, Farb A,Weber DK, MalcomGT, Smialek J, Virmani R. Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression. Circulation 2001;103:934-940. (Pubitemid 32183797)
27. Arbustini E, Dal Bello B, Morbini P, Gavazzi A, Specchia G, Vigano M. Multiple coronary thrombosis and allograft vascular disease. Transpl Proc 1998;30:1922-1924. (Pubitemid 28399370)
28. Arbustini E, Dal Bello B, Morbini P, Grasso M, Diegoli M, Fasani R, Pilotto A, Bellini O, Pellegrini C, Martinelli L, Campagna C, Gavazzi A, Specchia G, Vigano M, RobertsWC.Frequency and characteristics of coronary thrombosis in the epicardial coronary arteries after cardiac transplantation. Am J Cardiol 1996;78:795-800. (Pubitemid 126657151)
29. Arbustini E, Dal Bello B, Morbini P, Gavazzi A, Specchia G, Vigano M. Immunohistochemical characterization of coronary thrombi in allograft vascular disease. Transplantation 2000;69:1095-1101. (Pubitemid 30217592)
30. Wenke K, Meiser B, Thiery J, Nagel D, von Scheidt W, Krobot K, Steinbeck G, Seidel D, Reichart B. Simvastatin initiated early after heart transplantation: 8-year prospective experience. Circulation 2003;107:93-97. (Pubitemid 36070939)
31. Sawada T, Shite J, Garcia-Garcia HM, Shinke T,Watanabe S, Otake H, Matsumoto D, Tanino Y, OgasawaraD, Kawamori H, Kato H, Miyoshi N, Yokoyama M, SerruysPW, Hirata K. Feasibility of combined use of intravascular ultrasound radiofrequency data analysis and optical coherence tomography for detecting thin-cap fibroatheroma. Eur Heart J 2008;29:1136-1146. (Pubitemid 351844891)
32. Ferrante G, Nakano M, Prati F, Niccoli G, Mallus MT, Ramazzotti V, Montone RA, Kolodgie FD, Virmani R, Crea F. High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study. Circulation 2010;122:2505-2513